To develop and deliver novel therapies to patients, Genmab has formed 20 strategic partnerships with biotechnology and pharmaceutical companies. 99% of the share capital and voting rights in Genmab AS, so that through shares and financial instruments they held the voting rights to 3,292,445 shares in Genmab AS, which amounts to 5. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer.
🌍 Genmab (GMAB) - Form 6-K Filing
Filing Date: 2022-07-20
Accepted: 2022-07-20 14:02:41
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: